title: Relapsing polychondritis: response to tocilizumab and association with colitis.
authors.affiliation: From the *School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland; †Pathology Department, ‡Gastroenterology Department, and §Rheumatology Department, Waikato Hospital, Hamilton, New Zealand.
authors.forename: Michael
authors.initials: M
authors.lastname: Plunkett
authors.forename: Duncan
authors.initials: D
authors.lastname: Lamont
authors.forename: Jim
authors.initials: J
authors.lastname: Brooker
authors.forename: Douglas
authors.initials: D
authors.lastname: White
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003092:Colitis / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D008297:Male; D011081:Polychondritis, Relapsing / Q000150:complications / Q000188:drug therapy*; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab